Monday, 2 February 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 2 February 2026
Vivacity
Vivacity
Latest News
Milestone PBAC victory finally lands

After a decade of wrangling, a recommendation from PBAC for a broad listing for this blockbuster drug has finally arrived in what the company has described as a 'red-letter day' for cancer treatment.

Next-gen blockbuster hits PBS
With the first biosimilar of Bayer's Eylea also among a handful of the new additions to the scheme this month
TODAY New to the PBS
TGA tick sets up PBAC win
Drug deferred by the PBAC last year pending TGA approval plus Seqirus buffs up Ferinject franchise with a new brand
TODAY Approvals Action
Most Popular
And again: Aussie MD departs
The third ANZ Country Head departure this month has been announced with this leader promoted to a global role in the US
30 January
Next blockbuster wave looms
Find out which drugs are about to start their blockbuster run transforming treatment paradigms and passing US$1B in sales
30 January
Another ANZ Country Head leaving
After four years in the top job, this Big Pharma leader has been promoted to a global role with the company already naming his successor
29 January
AZ scrambles for $100M market
Market threatened by early generic competition, with AstraZeneca petitioning a judge to block the PBS listing
29 January
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (16)

Access & Reimbursement (1)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (5)

Executive Roles (4)

Other (16)

More News
Ex-Aussie GM wins top promotion
Former boss vastly expands his leadership territory as the company doubles down on its mission to win in this red-hot therapeutic space
28 January
FDA-approved gene therapy nears
A genetically modified therapy for bladder cancer already FDA approved could soon be studied in Aussie patients
30 January
TGA alert over AbbVie counterfeits
Company confirms products are fake with the regulator urging consumers to take extreme caution when buying medicines online
30 January
Roche arrives late but with a bang
Although late to the party, Roche's investment in the obesity space has yielded a real challenger to its rivals but can it catch up?
29 January
Aussie exec rings Nasdaq bell
Well-known Australian pharma leader rings the closing bell at the famous US stock exchange in New York to mark a major milestone
29 January
Rejected drug launches OS
After failing to win a PBAC recommendation, local company takes new breast cancer treatment to another geography
29 January
Ex-Aussie GM's golden career run
ICYMI: Former Country Leader promoted, doubling his leadership territory plus the other most popular stories this week
30 January Your Week in 5 Minutes
New cancer drug targets Australia
US clinical stage oncology company hopes to trial its lead candidate in Australian patients with locally advanced rectal cancer
28 January
Warehouse collapse hits supply
Floor cave-in at the warehouse which houses Queensland's only vaccine stockpile has left GPs complaining about supply delays
28 January
New jobs locked in for 2026
With January all but gone, companies are consolidating their teams amid a flurry of promotions, new hires and departures
28 January
Heart drug hits 'moment of truth'
Aussie-owned drug candidate has the potential to completely transform treatment for stroke and heart attack victims
28 January
Top 50 PBS drugs revealed
The drugs earning the most from the Federal Government have been listed, with a change at the top and three companies dominating
27 January
New pharma bumps up portfolio
Two fresh partnerships sealed in the past month for the ongoing supply and distribution of medicines to Australian patients
27 January
Industry cashes in on 'going green'
The second TIME Best Companies in Sustainable Growth list show even more pharmas are boosting environment sustainability along with revenues
27 January
PiF Advertise
PiF Advertise
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe